Mechanism of Anti-α-Synuclein Immunotherapy
Jun Sung Lee, Seung-Jae Lee
JMD. 2016;9(1):14-19.   Published online 2016 Jan 25     DOI:
Citations to this article as recorded by Crossref logo
The Associations between Immunological Reactivity to the Haptenation of Unconjugated Bisphenol A to Albumin and Protein Disulfide Isomerase with Alpha-Synuclein Antibodies
Datis Kharrazian, Martha Herbert, Aristo Vojdani
Toxics.2019; 7(2): 26.     CrossRef
Translational therapies for multiple system atrophy: Bottlenecks and future directions
Nadia Stefanova
Autonomic Neuroscience.2018; 211: 7.     CrossRef
Integrin CD11b mediates α-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway
Liyan Hou, Xiuqi Bao, Caixia Zang, Hanyu Yang, Fuqiang Sun, Yuning Che, Xuefei Wu, Shao Li, Dan Zhang, Qingshan Wang
Redox Biology.2018; 14: 600.     CrossRef
Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood
Isabell Kuhn, Tobias Rogosch, Theresa I. Schindler, Björn Tackenberg, Michael Zemlin, Rolf F. Maier, Richard Dodel, Yannick Kronimus
Journal of Neuroimmunology.2018; 315: 33.     CrossRef
Beneficial Effects of Flavonoids Against Parkinson's Disease
Un Ju Jung, Sang Ryong Kim
Journal of Medicinal Food.2018; 21(5): 421.     CrossRef
Unconventional protein secretion – new insights into the pathogenesis and therapeutic targets of human diseases
Jiyoon Kim, Heon Yung Gee, Min Goo Lee
Journal of Cell Science.2018; 131(12): jcs213686.     CrossRef
Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
Martin Kallab, Marcos Herrera-Vaquero, Malin Johannesson, Fredrik Eriksson, Jessica Sigvardson, Werner Poewe, Gregor K. Wenning, Eva Nordström, Nadia Stefanova
Frontiers in Neuroscience.2018;[Epub]     CrossRef
Gene therapy for neurological disorders: progress and prospects
Benjamin E. Deverman, Bernard M. Ravina, Krystof S. Bankiewicz, Steven M. Paul, Dinah W. Y. Sah
Nature Reviews Drug Discovery.2018; 17(9): 641.     CrossRef
Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
Khosro Jamebozorgi, Eskandar Taghizadeh, Daryoush Rostami, Hosein Pormasoumi, George E. Barreto, Seyed Mohammad Gheibi Hayat, Amirhossein Sahebkar
Molecular Neurobiology.2018;[Epub]     CrossRef
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects
Julianna J. Tomlinson, Bojan Shutinoski, Li Dong, Fanyi Meng, Dina Elleithy, Nathalie A. Lengacher, Angela P. Nguyen, Greg O. Cron, Qiubo Jiang, Erik D. Roberson, Robert L. Nussbaum, Nour K. Majbour, Omar M. El-Agnaf, Steffany A. Bennett, Diane C. Lagace,
Journal of Neural Transmission.2017; 124(6): 721.     CrossRef
Structure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson’s Disease
Xiaoli Si, Jiali Pu, Baorong Zhang
Journal of Movement Disorders.2017; 10(2): 69.     CrossRef
Membrane Trafficking Illuminates a Path to Parkinson’s Disease
Takafumi Hasegawa, Naoto Sugeno, Akio Kikuchi, Toru Baba, Masashi Aoki
The Tohoku Journal of Experimental Medicine.2017; 242(1): 63.     CrossRef
Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
J. Teister, F. Anders, S. Beck, S. Funke, H. von Pein, V. Prokosch, N. Pfeiffer, F. Grus
Scientific Reports.2017;[Epub]     CrossRef
Impact of aging immune system on neurodegeneration and potential immunotherapies
Zhanfeng Liang, Yang Zhao, Linhui Ruan, Linnan Zhu, Kunlin Jin, Qichuan Zhuge, Dong-Ming Su, Yong Zhao
Progress in Neurobiology.2017; 157: 2.     CrossRef
A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies
Jess-Karan S. Dhillon, Cara Riffe, Brenda D. Moore, Yong Ran, Paramita Chakrabarty, Todd E. Golde, Benoit I. Giasson, Stephan N. Witt
PLOS ONE.2017; 12(9): e0184731.     CrossRef
Vaccination strategies in tauopathies and synucleinopathies
Anne K. Braczynski, Jörg B. Schulz, Jan-Philipp Bach
Journal of Neurochemistry.2017; 143(5): 467.     CrossRef
Missions of <italic>Journal of Movement Disorders</italic>
Yun Joong Kim
Journal of Movement Disorders.2016; 9(1): 1.     CrossRef
How strong is the evidence that Parkinsonʼs disease is a prion disorder?
Patrik Brundin, Jiyan Ma, Jeffrey H. Kordower
Current Opinion in Neurology.2016; 29(4): 459.     CrossRef